AstraZeneca Stock Quote AZN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

69.51

( 0.09% )

Bid

65.00

Ask

71.40

Volume

4,114,643

69.31 Day's Range 70.02

0.00 52 Week Range 0.00

Market Cap

215.572B

Previous Close

69.45

Open

69.965

Last Trade

69.8499

Last Trade Time

Financial Volume

$ 286,821,386

VWAP

69.7075

Average Volume (3m)

Shares Outstanding

3,101,315,924

Dividend Yield

2.22%

PE Ratio

45.04

Earnings Per Share (EPS)

2.27

Revenue

54.07B

Net Profit

7.04B

AstraZeneca is a global science-led biopharmaceutical company that focuses on the discovery development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put s... AstraZeneca is a global science-led biopharmaceutical company that focuses on the discovery development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive open and collaborative. This approach runs through all that we do. We focus on three main therapy areas Oncology Cardiovascular & Metabolic Disease CVMD and Respiratory and we are also selectively active in the areas of autoimmunity neuroscience and infection. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.astrazeneca.com

Headquarters

Cambridge, Gbr

Founded

AstraZeneca PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AZN. The last closing price for AstraZeneca was $69.45. Over the last year, AstraZeneca shares have traded in a share price range of $ 0.00 to $ 0.00.

AstraZeneca currently has 3,101,315,924 shares outstanding. The market capitalization of AstraZeneca is $215.39 billion. AstraZeneca has a price to earnings ratio (PE ratio) of 45.04.

Overall Flow

Bullish

Net Premium

101k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Summit Therapeutics Shares Climb Amid Rumored $15B Deal Talks with AstraZeneca

Shares of Summit Therapeutics (NASDAQ:SMMT) jumped 5% on Thursday following reports that the company is in advanced negotiations with AstraZeneca...

AstraZeneca shares climb amid rumors CEO prefers U.S. stock listing

AstraZeneca PLC (NASDAQ:AZN) saw its American Depositary Receipts (ADRs) increase by 2.2% following a report from The Times suggesting that CEO...

DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

Based on TROPION-Lung05 results and supported by data from TROPION-Lung01 First and only TROP2-directed therapy approved in the US for the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease progression or death by 44% vs. THP as 1st-line therapy in patients with HER2-positive metastatic breast cancer in DESTINY-Breast09 Phase III trial

AstraZeneca and Daiichi Sankyo’s ENHERTU plus pertuzumab showed a median progression-free survival greater than three years First trial in more...

IMFINZI® (durvalumab) regimen reduced risk of progression, recurrence or death by 29% in early-stage gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

Two-thirds (67.4%) of patients treated with IMFINZI-based perioperative regimen remained event-free at two years First and only immunotherapy to...

Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

First pivotal trial to demonstrate clinical value of monitoring circulating tumor DNA to detect and treat emerging resistance in 1st-line therapy...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

AZN - Frequently Asked Questions (FAQ)

What is the current AstraZeneca share price?

The current share price of AstraZeneca is $ 69.51

How many AstraZeneca shares are in issue?

AstraZeneca has 3,101,315,924 shares in issue

What is the market cap of AstraZeneca?

The market capitalisation of AstraZeneca is USD 215.39B

What is the 1 year trading range for AstraZeneca share price?

AstraZeneca has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of AstraZeneca?

The price to earnings ratio of AstraZeneca is 45.04

What is the cash to sales ratio of AstraZeneca?

The cash to sales ratio of AstraZeneca is 5.86

What is the reporting currency for AstraZeneca?

AstraZeneca reports financial results in USD

What is the latest annual turnover for AstraZeneca?

The latest annual turnover of AstraZeneca is USD 54.07B

What is the latest annual profit for AstraZeneca?

The latest annual profit of AstraZeneca is USD 7.04B

What is the registered address of AstraZeneca?

The registered address for AstraZeneca is 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA

What is the AstraZeneca website address?

The website address for AstraZeneca is www.astrazeneca.com

Which industry sector does AstraZeneca operate in?

AstraZeneca operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MBIOMustang Bio Inc	$ 3.3399 (180.66%)	255.3M
CURRCurrenc Group Inc	$ 1.98 (90.38%)	32.14M
ELPWElong Power Holding Ltd	$ 1.935 (63.98%)	12.47M
ASSTAsset Entities Inc	$ 6.9801 (63.47%)	90.74M
VIOTViomi Technology Company Ltd	$ 2.635 (58.73%)	14.25M
SKBLSkyline Builders Group Holding Ltd	$ 1.51 (-87.82%)	12.76M
WAITop KingWin Ltd	$ 0.73 (-79.89%)	11.57M
JSPRJasper Therapeutics Inc	$ 3.015 (-55.47%)	12.37M
BGLBlue Gold Limited	$ 73.90 (-31.35%)	391.43k
LRHCLa Rosa Holdings Corporation	$ 8.3799 (-30.17%)	387.95k
MULNMullen Automotive Inc	$ 0.2388 (6.85%)	318.27M
MBIOMustang Bio Inc	$ 3.3399 (180.66%)	278.74M
BTOGBit Origin Ltd	$ 0.254 (47.67%)	277.98M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 9.98 (-13.44%)	239.93M
HCTIHealthcare Triangle Inc	$ 0.0227 (-11.33%)	225.62M